POSTERS ASCO 2024

Cáncer de pulmón

Carcinoma pulmonar no microcítico metastásico

Germline NQO1c.559C>T as a biomarker of genetic susceptibility to immune checkpoint blockade resistance.

Germline NQO1c.559C>T as a biomarker of genetic susceptibility to immune checkpoint blockade resistance.

Abstract: 8537 Poster Bd #: 401

Poster

Descargar

Autor
José Carlos Benítez, MD, MSc

Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Biomedical Research Institute of Málaga (IBIMA BIONAND Platform)

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON